vimarsana.com

Latest Breaking News On - Tourlite fund - Page 1 : vimarsana.com

Do You Think the Management of Roivant Sciences (ROIV) Can Create Value?

Tourlite Capital Management, an investment management firm, released its fourth quarter 2023 investor letter, a copy of which can be downloaded here. Tourlite Fund, LP Founder Class returned 1.1% for Q4 2023 and 8.8% for the year. Since its inception in April 2022, the fund returned 14.3% compared to 8.4%, and 0.5% returns for the S&P […]

Is Franklin Covey (FC) Trading at a Significant Discount?

Tourlite Capital Management, an investment management firm, released its fourth quarter 2023 investor letter, a copy of which can be downloaded here. Tourlite Fund, LP Founder Class returned 1.1% for Q4 2023 and 8.8% for the year. Since its inception in April 2022, the fund returned 14.3% compared to 8.4%, and 0.5% returns for the S&P […]

Here s What Happened to Latch (LTCH) in Q4

Tourlite Capital Management, an investment management firm, released its fourth quarter 2023 investor letter, a copy of which can be downloaded here.

Should You Sell Esperion Therapeutics (ESPR)?

Tourlite Capital Management, an investment management firm, released its fourth quarter 2023 investor letter, a copy of which can be downloaded here.

Reasons for the Outperformance of FTAI Aviation (FTAI) in Q4

Tourlite Capital Management, an investment management firm, released its fourth quarter 2023 investor letter, a copy of which can be downloaded here. Tourlite Fund, LP Founder Class returned 1.1% for Q4 2023 and 8.8% for the year. Since its inception in April 2022, the fund returned 14.3% compared to 8.4%, and 0.5% returns for the S&P […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.